234 related articles for article (PubMed ID: 19591935)
1. Altered responses of dopamine D3 receptor null mice to excitotoxic or anxiogenic stimuli: Possible involvement of the endocannabinoid and endovanilloid systems.
Micale V; Cristino L; Tamburella A; Petrosino S; Leggio GM; Drago F; Di Marzo V
Neurobiol Dis; 2009 Oct; 36(1):70-80. PubMed ID: 19591935
[TBL] [Abstract][Full Text] [Related]
2. Anxiolytic effects in mice of a dual blocker of fatty acid amide hydrolase and transient receptor potential vanilloid type-1 channels.
Micale V; Cristino L; Tamburella A; Petrosino S; Leggio GM; Drago F; Di Marzo V
Neuropsychopharmacology; 2009 Feb; 34(3):593-606. PubMed ID: 18580871
[TBL] [Abstract][Full Text] [Related]
3. The endocannabinoid and endovanilloid systems interact in the rat prelimbic medial prefrontal cortex to control anxiety-like behavior.
Fogaça MV; Aguiar DC; Moreira FA; Guimarães FS
Neuropharmacology; 2012 Aug; 63(2):202-10. PubMed ID: 22691536
[TBL] [Abstract][Full Text] [Related]
4. Decreased endocannabinoid levels in the brain and beneficial effects of agents activating cannabinoid and/or vanilloid receptors in a rat model of multiple sclerosis.
Cabranes A; Venderova K; de Lago E; Fezza F; Sánchez A; Mestre L; Valenti M; García-Merino A; Ramos JA; Di Marzo V; Fernández-Ruiz J
Neurobiol Dis; 2005 Nov; 20(2):207-17. PubMed ID: 16242629
[TBL] [Abstract][Full Text] [Related]
5. Endocannabinoids activate transient receptor potential vanilloid 1 receptors to reduce hyperdopaminergia-related hyperactivity: therapeutic implications.
Tzavara ET; Li DL; Moutsimilli L; Bisogno T; Di Marzo V; Phebus LA; Nomikos GG; Giros B
Biol Psychiatry; 2006 Mar; 59(6):508-15. PubMed ID: 16199010
[TBL] [Abstract][Full Text] [Related]
6. The endocannabinoid, endovanilloid and nitrergic systems could interact in the rat dorsolateral periaqueductal gray matter to control anxiety-like behaviors.
Batista PA; Fogaça MV; Guimarães FS
Behav Brain Res; 2015 Oct; 293():182-8. PubMed ID: 26187694
[TBL] [Abstract][Full Text] [Related]
7. Multiple Forms of Endocannabinoid and Endovanilloid Signaling Regulate the Tonic Control of GABA Release.
Lee SH; Ledri M; Tóth B; Marchionni I; Henstridge CM; Dudok B; Kenesei K; Barna L; Szabó SI; Renkecz T; Oberoi M; Watanabe M; Limoli CL; Horvai G; Soltesz I; Katona I
J Neurosci; 2015 Jul; 35(27):10039-57. PubMed ID: 26157003
[TBL] [Abstract][Full Text] [Related]
8. Human brain endothelium: coexpression and function of vanilloid and endocannabinoid receptors.
Golech SA; McCarron RM; Chen Y; Bembry J; Lenz F; Mechoulam R; Shohami E; Spatz M
Brain Res Mol Brain Res; 2004 Dec; 132(1):87-92. PubMed ID: 15548432
[TBL] [Abstract][Full Text] [Related]
9. Enhanced cognitive performance of dopamine D3 receptor "knock-out" mice in the step-through passive-avoidance test: assessing the role of the endocannabinoid/endovanilloid systems.
Micale V; Cristino L; Tamburella A; Petrosino S; Leggio GM; Di Marzo V; Drago F
Pharmacol Res; 2010 Jun; 61(6):531-6. PubMed ID: 20149873
[TBL] [Abstract][Full Text] [Related]
10. Arvanil, anandamide and N-arachidonoyl-dopamine (NADA) inhibit emesis through cannabinoid CB1 and vanilloid TRPV1 receptors in the ferret.
Sharkey KA; Cristino L; Oland LD; Van Sickle MD; Starowicz K; Pittman QJ; Guglielmotti V; Davison JS; Di Marzo V
Eur J Neurosci; 2007 May; 25(9):2773-82. PubMed ID: 17459108
[TBL] [Abstract][Full Text] [Related]
11. Transient receptor potential vanilloid 1 channels control acetylcholine/2-arachidonoylglicerol coupling in the striatum.
Musella A; De Chiara V; Rossi S; Cavasinni F; Castelli M; Cantarella C; Mataluni G; Bernardi G; Centonze D
Neuroscience; 2010 May; 167(3):864-71. PubMed ID: 20219639
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory CB1 and activating/desensitizing TRPV1-mediated cannabinoid actions on CGRP release in rodent skin.
Engel MA; Izydorczyk I; Mueller-Tribbensee SM; Becker C; Neurath MF; Reeh PW
Neuropeptides; 2011 Jun; 45(3):229-37. PubMed ID: 21514666
[TBL] [Abstract][Full Text] [Related]
13. Anxiolytic-like properties of the anandamide transport inhibitor AM404.
Bortolato M; Campolongo P; Mangieri RA; Scattoni ML; Frau R; Trezza V; La Rana G; Russo R; Calignano A; Gessa GL; Cuomo V; Piomelli D
Neuropsychopharmacology; 2006 Dec; 31(12):2652-9. PubMed ID: 16541083
[TBL] [Abstract][Full Text] [Related]
14. Endocannabinoid regulation of spinal nociceptive processing in a model of neuropathic pain.
Sagar DR; Jhaveri MD; Richardson D; Gray RA; de Lago E; Fernández-Ruiz J; Barrett DA; Kendall DA; Chapman V
Eur J Neurosci; 2010 Apr; 31(8):1414-22. PubMed ID: 20384778
[TBL] [Abstract][Full Text] [Related]
15. Pre-training anandamide infusion within the basolateral amygdala impairs plus-maze discriminative avoidance task in rats.
Munguba H; Cabral A; Leão AH; Barbosa FF; Izídio GS; Ribeiro AM; Silva RH
Neurobiol Learn Mem; 2011 May; 95(4):527-33. PubMed ID: 21440651
[TBL] [Abstract][Full Text] [Related]
16. Endocannabinoids mediate anxiolytic-like effect of acetaminophen via CB1 receptors.
Umathe SN; Manna SS; Utturwar KS; Jain NS
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Oct; 33(7):1191-9. PubMed ID: 19580839
[TBL] [Abstract][Full Text] [Related]
17. Cannabinoids induce apathetic and impulsive patterns of choice through CB1 receptors and TRPV1 channels.
Fatahi Z; Reisi Z; Rainer G; Haghparast A; Khani A
Neuropharmacology; 2018 May; 133():75-84. PubMed ID: 29355640
[TBL] [Abstract][Full Text] [Related]
18. Analgesic actions of N-arachidonoyl-serotonin, a fatty acid amide hydrolase inhibitor with antagonistic activity at vanilloid TRPV1 receptors.
Maione S; De Petrocellis L; de Novellis V; Moriello AS; Petrosino S; Palazzo E; Rossi FS; Woodward DF; Di Marzo V
Br J Pharmacol; 2007 Mar; 150(6):766-81. PubMed ID: 17279090
[TBL] [Abstract][Full Text] [Related]
19. The endovanilloid/endocannabinoid system in human osteoclasts: possible involvement in bone formation and resorption.
Rossi F; Siniscalco D; Luongo L; De Petrocellis L; Bellini G; Petrosino S; Torella M; Santoro C; Nobili B; Perrotta S; Di Marzo V; Maione S
Bone; 2009 Mar; 44(3):476-84. PubMed ID: 19059369
[TBL] [Abstract][Full Text] [Related]
20. Dopamine D3 receptor-dependent changes in alpha6 GABAA subunit expression in striatum modulate anxiety-like behaviour: Responsiveness and tolerance to diazepam.
Leggio GM; Torrisi SA; Castorina A; Platania CB; Impellizzeri AA; Fidilio A; Caraci F; Bucolo C; Drago F; Salomone S
Eur Neuropsychopharmacol; 2015 Sep; 25(9):1427-36. PubMed ID: 25482686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
